KESITEL

This brand name is authorized in Nigeria.

Active ingredients

The drug KESITEL contains one active pharmaceutical ingredient (API):

1	Albendazole UNII F4216019LN - ALBENDAZOLE
	Albendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules.
	Read more about Albendazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-9609	Tablet	KESITEL TABLETS ALBENDAZOLE USP 400 MG TAB 400 mg 1 X 1	71 RNW-PP-394503 KESITEL TABLETS ALBENDAZOLE USP 400 MG Albendazole USP 400mg. Excipients: Microcrystalline cellulose, Lactose, Mannitol, Sodium Carboxymethyl Cellulose, Sodium benzoate, Citric Acid Monohydrate, Colour Sunset Yellow Supra, Sodium starch glycolate, Magnesium stearate, Colloidal Anhydrous Silica, Purified talc, Aspartame, Sodium chloride, Flavour: Orange powder B4-9609 Drugs Imported Products 1X1 POM 1 12/6/2023 KESSINGTON GLOBAL SYNERGY LTD, GOVERNORS WAY MAPLE WOOD ESTATE OKO-OBA LAGOS AGEGE LAGOS 9093313563 sammville@gmail.com RATNATRIS PHARMACEUTICALS PVT.,LTD, SURVEY N0.416, AT.INDRAD, TA. KADI. DIST MEHSANA-382715, GUJARAT, INDIA, India	28/02/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P02CA03	Albendazole	P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CA Benzimidazole derivatives
Discover more medicines within P02CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-9609